Cardiac toxicity associated with HCV direct antiviral agents
Saved in:
| Main Authors: | Claudio Ucciferri, Alessandro Occhionero, Jacopo Vecchiet, Katia Falasca |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2018-10-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | https://www.mjhid.org/index.php/mjhid/article/view/3757 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antivirals against HCV infection: the story thus far
by: Ahmad Adebayo Irekeola, et al.
Published: (2022-02-01) -
Efficacy and safety of directly acting antiviral drugs in HCV patients with HIV in liver transplantation: A meta-analysis
by: Tian Zeng, et al.
Published: (2023-01-01) -
Elimination of HCV replication machinery early after antiviral treatment with DAA monitored by multimodal microscopy
by: Castro Victoria, et al.
Published: (2024-01-01) -
The Efficacy and Safety of Sofosbuvir Containing Regimen in the Treatment of Hcv Infection in Patients with Haemoglobinopathy
by: Nawfal R Hussein
Published: (2017-01-01) -
Worsening of Controlled Attenuation Parameter and Metabolic Profile After HCV Cure in People with HIV as a Sign of Steatosis
by: Alessia Siribelli, et al.
Published: (2025-06-01)